Apitope

About:

Apitope is a European biotech company

Website: http://apitope.com/

Top Investors: PMV Pharmaceuticals, Vesalius Biocapital Partners, Limburgse Reconversie Maatschappij, Arthurian Life Sciences, Wyvern Seed Fund

Description:

Apitope is a biotech company focused on the discovery and development of disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves’ disease, Factor VIII intolerance and uveitis. The company, whose first product candidate is licensed to Merck Serono, will now progress its remaining portfolio of product candidates developed with its proprietary platform technology.